Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Uncover Ways To Visualize Financial Goal Progress with charts and visuals that make progress tangible, boosting motivation and consistency.
21,483 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
NIO reports its first-ever quarterly profit, but shares fall while Tesla leads a modest rally, illustrating the two-s...
Investors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
SpaceX is pursuing a bold, trillion-dollar plan to become the backbone of global connectivity. As markets watch, inve...
ScrollTech earns Deloitte’s nod as the fastest-growing software firm in North America and launches a pre-IPO round ti...
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
GM authorized a $6 billion buyback and boosted its dividend, signaling a shift toward disciplined cash returns. Ford,...
Caesars Entertainment moves to go private in a $17.6 billion deal, and investors are eyeing four lagging U.S. compani...
Institutional holders control roughly 87% of Starbucks' float, and analysts expect further upside as comps improve an...
Silver prices climb in 2026, lifting pure-play silver miners trading below $30. Investors weigh the appeal of physica...
AMD posts a 55% month gain as AI data center demand accelerates, eclipsing Intel’s advance. The move sparks a debate ...
DraftKings is under renewed scrutiny as it rolls out Predictions and posts a mixed Q1 2026. Our price prediction: dkn...